20 February – LAWFUEL – The Law News Network – Freshfields Bruckhaus Deringer has advised emerging global pharmaceutical company Dr. Reddy’s on the acquisition of betapharm, the fourth-largest generic pharmaceuticals company in Germany, from private equity house 3i for €480m in cash.
This transaction is reported to be the largest acquisition of a European company by an Indian company ever. Freshfields Munich-based partner Ferdinand Fromholzer commented: ‘We were delighted Dr Reddy’s trusted our expertise in the complex European private equity arena to help them with this landmark acquisition.’
The Freshfields team included partners Simon Hall (finance, London), Tobias Mueller-Deku (finance, Munich), Christian Sistermann (tax, Munich), Marc Reysen (ACT, Brussels) and senior associate Henning Moelle (pharma law, Frankfurt).
